| 297 |
Inhibition of retinaldehyde dehydrogenase leads to population decline |
Young Jun Kim |
BY-SA |
1637: Retinaldehyde dehydrogenase inhibition
|
360: Decrease, Population growth rate
|
Under Development |
1.77 |
| 296 |
Oxidative DNA damage leading to chromosomal aberrations and mutations |
Carole Yauk |
BY-SA |
1634: Increase, Oxidative DNA damage
|
2 AOs
|
WPHA/WNT Endorsed |
1.76 |
| 313 |
Stimulation of TLR7/8 in dendric cells leading to Psoriatic skin disease |
Hiroyuki Komatsu |
BY-SA |
1706: Stimulation, TLR7/8
|
1709: Psoriatic skin disease
|
Under Development |
1.75 |
| 315 |
Inhibition of JAK3 leading to impairment of T-Cell Dependent Antibody Response |
Yasuhiro Yoshida |
BY-SA |
1715: Inhibition of JAK3
|
1719: Impairment of T-cell dependent antibody response
|
Under Development |
1.74 |
| 314 |
Binding to estrogen receptor (ER)-α in immune cells leading to exacerbation of systemic lupus erythematosus (SLE) |
Yasuharu Otsubo |
BY-SA |
1710: Binding to estrogen receptor (ER)-α in immune cells
|
1714: Exacerbation of systemic lupus erythematosus (SLE)
|
Under Development |
1.73 |
| 150 |
Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF |
Amani Farhat |
BY-SA |
18: Activation, AhR
|
947: Increase, Early Life Stage Mortality
|
WPHA/WNT Endorsed |
1.7 |
| 41 |
Sustained AhR Activation leading to Rodent Liver Tumours |
Undefined |
BY-SA |
165: Activation, Long term AHR receptor driven direct and indirect gene expression changes
|
856: Formation, Hepatocellular and Bile duct tumors
|
Under Review |
1.7 |
| 131 |
Aryl hydrocarbon receptor activation leading to uroporphyria |
Amani Farhat |
BY-SA |
18: Activation, AhR
|
369: Uroporphyria
|
WPHA/WNT Endorsed |
1.7 |
| 316 |
Trypsin inhibition leading to pancreatic acinar cell tumors |
Shigeru Hisada |
BY-SA |
1720: Trypsin inhibition
|
1725: Pancreatic acinar cell tumors
|
Under Development |
1.60 |
| 43 |
Disruption of VEGFR Signaling Leading to Developmental Defects |
Undefined |
BY-SA |
305: Inhibition, VegfR2
|
1001: Increased, Developmental Defects
|
WPHA/WNT Endorsed |
1.6 |
| 271 |
Inhibition of thyroid peroxidase leading to impaired fertility in fish |
June-Woo Park |
BY-SA |
279: Thyroperoxidase, Inhibition
|
78: Reduction, Cumulative fecundity and spawning
|
Under Development |
1.59 |
| 298 |
Increase in reactive oxygen species (ROS) leading to human treatment-resistant gastric cancer |
Shihori Tanabe |
BY-SA |
1115: Increase, Reactive oxygen species
|
1651: Treatment-resistant gastric cancer
|
Under Review |
1.58 |
| 272 |
Deposition of energy leading to lung cancer |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
1556: Increase, lung cancer
|
WPHA/WNT Endorsed |
1.56 |
| 237 |
Substance interaction with lung resident cell membrane components leading to atherosclerosis via acute phase response |
Ulla Vogel |
BY-SA |
1495: Substance interaction with the lung resident cell membrane components
|
1443: Atherosclerosis
|
Under Development |
1.55 |
| 206 |
Peroxisome proliferator-activated receptors γ inactivation leading to lung fibrosis |
Jinhee Choi |
BY-SA |
1270: Inactivation of PPARγ
|
1276: Lung fibrosis
|
Under Development |
1.54 |
| 202 |
Inhibitor binding to topoisomerase II leading to infant leukaemia |
Andrea Terron |
BY-SA |
1252: Binding to (interferes with) topoisomerase II enzyme
|
1254: Infant leukaemia
|
WPHA/WNT Endorsed |
1.53 |
| 212 |
Histone deacetylase inhibition leading to testicular atrophy |
Shihori Tanabe |
BY-SA |
1502: Histone deacetylase inhibition
|
1506: Testicular atrophy
|
WPHA/WNT Endorsed |
1.52 |
| 148 |
EGFR Activation Leading to Decreased Lung Function |
Karsta Luettich |
BY-SA |
941: Activation, EGFR
|
1250: Decrease, Lung function
|
Under Development |
1.51 |
| 149 |
Peptide Oxidation Leading to Hypertension |
Frazer Lowe |
BY-SA |
209: Peptide Oxidation
|
952: Hypertension
|
Under Development |
1.50 |
| 282 |
Adverse outcome pathway on photochemical toxicity initiated by light exposure |
Satomi Onoue |
BY-SA |
1115: Increase, Reactive oxygen species
|
1599: Inflamatory events in light-exposed tissues
|
Under Review |
1.49 |
| 277 |
Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response |
Takao Ashikaga |
BY-SA |
1700: Impaired IL-1R1 signaling in T cell
|
984: Impairment, T-cell dependent antibody response
|
WPHA/WNT Endorsed |
1.48 |
| 144 |
Endocytic lysosomal uptake leading to liver fibrosis |
Marina Kuburic |
BY-SA |
1539: Endocytotic lysosomal uptake
|
344: Increase, Liver fibrosis
|
Under Review |
1.47 |
| 261 |
L-type calcium channel blockade leading to heart failure via decrease in cardiac contractility |
Luigi Margiotta-Casaluci |
BY-SA |
1529: Blockade, L-Type Calcium Channels
|
1535: Heart failure
|
Under Development |
1.45 |
| 262 |
L-type calcium channel blockade leading to the disruption of cardiac electrophysiology |
Luigi Margiotta-Casaluci |
BY-SA |
None
|
None
|
Under Development |
1.45 |
| 283 |
L-type calcium channel blockade leading to hypotension |
Luigi Margiotta-Casaluci |
BY-SA |
None
|
None
|
Under Development |
1.45 |